A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Key facts

Sponsor

Guangxi Medical University

Principal Investigator

Wang R. sheng, M.D.

Department of Radiotherapy，the First Affiliated Hospital of Guangxi Medical University

Intervention

nedaplatin and docetaxel(drug)

Enrollment

2 target

Eligibility

18-70 years · All sexes

Timeline

2011 – 2017

Study locations (1)

• Department of Radiotherapy，the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China

Collaborators

People's Hospital of Guangxi Zhuang Autonomous Region · 303rd Hospital of the People's Liberation Army · Nanning Second People's Hospital · Guangxi Traditional Chinese Medical University · Guilin Medical College · Guangxi Naxishan Hospital · Liuzhou Workers' Hospital · LiuZhou People's Hospital · Liuzhou Hospital of Traditional Chinese Medicine · Liuzhou Cancer Hospital · Liuzhou Railway hospital · First People's Hospital of Yulin · The Red Cross hospital of YuLin · Guigang People's Hospital · Wuzhou Red Cross Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Nasopharyngeal carcinoma

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT06980038
  Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
  National Cancer Institute (NCI)
• RECRUITINGPHASE1NCT07584499
  Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
  Sun Yat-sen University
• RECRUITINGPHASE2NCT07362979
  Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma
  Sun Yat-sen University
• RECRUITINGPHASE3NCT07459296
  Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
  First Affiliated Hospital of Guangxi Medical University
• RECRUITINGNANCT06796270
  Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma
  The Second Affiliated Hospital of Hainan Medical University
• RECRUITINGPHASE2NCT06059261
  Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
  Chongqing University Cancer Hospital
• RECRUITINGNCT07376603
  IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features
  Qiaojuan Guo
• RECRUITINGPHASE3NCT07340515
  Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial
  Man Hu

See all trials for Nasopharyngeal carcinoma →